Vitale Christopher V 4
4 · AMREP CORP. · Filed Jul 14, 2026
Research Summary
AI-generated summary of this filing
AMREP (AXR) CEO Christopher Vitale Receives Restricted Stock Award
What Happened Christopher V. Vitale, President, CEO and a director of AMREP Corporation (AXR), received a grant of 8,700 restricted shares on July 13, 2026. The Form 4 reports an acquisition at $0.00 per share (total reported value $0), reflecting a standard restricted stock award rather than an open-market purchase or sale.
Key Details
- Transaction date: July 13, 2026; Form 4 filed July 14, 2026 (timely filing).
- Transaction type/code: Award/Grant (A) — 8,700 restricted shares granted at $0.00.
- Vesting: 2,900 shares vest on July 13 of 2027, 2028 and 2029, subject to continued employment (per footnote).
- Shares owned after the transaction: not specified in the provided filing.
- No 10b5-1 plan, tax-withholding sale, or exercise noted in this filing.
Context Restricted stock awards are compensation that typically vests over time and are intended to align executive and shareholder interests; they are not the same as a market purchase and do not necessarily indicate immediate buying or selling intent. For dollar value at grant or broader compensation context, review AMREP’s proxy or annual compensation disclosures.
Insider Transaction Report
- Award
Common Stock
[F1]2026-07-13+8,700→ 125,900 total
Footnotes (1)
- [F1]Grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan. The restricted stock will vest as follows: 2,900 shares on July 13, 2027, 2,900 shares on July 13, 2028 and 2,900 shares on July 13, 2029, subject to the continued employment of Mr. Vitale by AMREP Corporation on each vesting date.